MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 219 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2023. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $364,478 | +21.0% | 42,039 | -8.6% | 0.00% | 0.0% |
| Q4 2023 | $301,313 | -32.6% | 46,002 | +2.8% | 0.00% | -50.0% |
| Q3 2023 | $447,000 | -27.7% | 44,746 | -10.0% | 0.00% | 0.0% |
| Q2 2023 | $618,000 | -19.2% | 49,703 | -9.0% | 0.00% | -33.3% |
| Q1 2023 | $765,000 | -5.0% | 54,593 | -3.0% | 0.00% | 0.0% |
| Q4 2022 | $805,000 | -42.8% | 56,289 | +2.1% | 0.00% | -50.0% |
| Q3 2022 | $1,407,000 | -9.4% | 55,108 | +0.8% | 0.01% | -14.3% |
| Q2 2022 | $1,553,000 | -22.8% | 54,674 | -4.1% | 0.01% | 0.0% |
| Q1 2022 | $2,012,000 | -18.6% | 57,032 | -3.4% | 0.01% | -12.5% |
| Q4 2021 | $2,473,000 | -11.1% | 59,020 | +4.1% | 0.01% | -20.0% |
| Q3 2021 | $2,783,000 | +54.9% | 56,702 | +31.6% | 0.01% | +66.7% |
| Q2 2021 | $1,797,000 | +41.4% | 43,073 | +20.7% | 0.01% | +20.0% |
| Q1 2021 | $1,271,000 | – | 35,674 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $269,495,240 | 12.63% |
| 12 West Capital Management LP | 3,361,836 | $41,787,621 | 3.59% |
| Alpine Peaks Capital, LP | 329,424 | $4,094,740 | 2.87% |
| Roubaix Capital, LLC | 235,480 | $2,927,016 | 2.15% |
| Prosight Management, LP | 628,600 | $7,813,498 | 1.17% |
| Cannon Global Investment Management, LLC | 15,800 | $196,394 | 1.02% |
| Curi Wealth Management, LLC | 566,417 | $7,040,564 | 0.95% |
| Mesirow Institutional Investment Management, Inc. | 693,376 | $8,618,664 | 0.89% |
| BRAIDWELL LP | 1,804,700 | $22,432,421 | 0.73% |
| Connacht Asset Management LP | 39,031 | $485,155 | 0.66% |